For a country, being ready to face an infectious disease outbreak requires, among other things, the capability to reach and involve all the components of the society. Especially those that are more exposed to health threats due to low quality housing, poor nutrition, lack of parental education and weak links to health services, as it happened in the 2010 measles epidemic in Bulgaria, where 90% of recorded cases occurred within the so-called Roma community.
The debate over measles vaccine is underway in many countries and, in some cases, the discussion came to court. It happened, for instance, in Italy in 2012, when a judge recognized the right to compensation (required by Italian law) for the family of a child vaccinated in 2002 with the trivalent vaccine MPR (measles-mumps-rubella) who were later diagnosed with autism. During the debate, the consultant of the family presented the research of the English physician Andrew Wakefield.
